Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

2 papers

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice

Ingmar Gorman, Elizabeth M Nielson, Aja Molinar, Ksenia Cassidy, Jonathan Sabbagh
PubMed Central (PMC) Summary & key facts 2021 124 citations

Psychedelic Harm Reduction and Integration (PHRI) is a clinical model for working with people who use or are thinking about using psychedelics. It blends harm-reduction therapy with methods from psychedelic-assisted therapy, can be used in short or ongoing psychotherapy, and aims to be compassionate and non-stigmatizing rather than focused only…

Chemical synthesis and alkaloids Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies

On the need for metaphysics in psychedelic therapy and research

Sjöstedt-Hughes, Peter
www.frontiersin.org Summary & key facts 2023 46 citations

This paper argues that psychedelic-assisted therapy should include optional, clear discussion of metaphysical views during integration. It presents a "Metaphysics Matrix" schema and a new "Metaphysics Matrix Questionnaire (MMQ)" as tools to help integrate and to measure metaphysical aspects of psychedelic experiences. The authors say metaphysics (a branch of philosophy…

Chemical synthesis and alkaloids Complementary and Alternative Medicine Studies Psychedelics and Drug Studies
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.